Free Trial

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies logo
$87.35
+0.15 (+0.17%)
(As of 10/31/2024 ET)

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
5
Buy
9

Based on 15 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a sell rating, 5 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$94.36
8.02% Upside
According to the 15 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $94.36. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $74.00. The average price target represents a forecasted upside of 8.02% from the current price of $87.35.
Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

Sign Up

GEHC Analyst Ratings Over Time

TypeCurrent Forecast
11/1/23 to 10/31/24
1 Month Ago
10/2/23 to 10/1/24
3 Months Ago
8/3/23 to 8/2/24
1 Year Ago
11/1/22 to 11/1/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
8 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$94.36$94.23$94.09$88.44
Forecasted Upside8.02% Upside2.79% Upside12.76% Upside29.53% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GE HealthCare Technologies Stock vs. The Competition

TypeGE HealthCare TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.79
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside8.06% Upside15,724.54% Upside9.23% Upside
News Sentiment Rating
Positive News

See Recent GEHC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/31/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$95.00 ➝ $96.00+9.90%
10/1/2024Evercore ISI
2 of 5 stars
 Boost TargetOutperform ➝ Outperform$98.00 ➝ $102.00+10.82%
9/30/2024Stifel Nicolaus
4 of 5 stars
 Boost TargetBuy ➝ Buy$100.00 ➝ $102.00+10.88%
9/26/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$84.00 ➝ $74.00-20.44%
9/18/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Zimmerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$100.00+15.22%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$90.00+5.77%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Ridley-Day
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$87.00+10.90%
5/1/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$94.00 ➝ $86.00+10.45%
5/1/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$110.00 ➝ $105.00+35.45%
4/3/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$88.00 ➝ $103.00+14.62%
4/1/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$80.00 ➝ $110.00+22.82%
2/15/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.24%
2/12/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$74.00 ➝ $86.00+3.40%
11/30/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$80.00+18.15%
5/15/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$97.00+29.45%
4/19/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$95.00+13.55%
1/19/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
1/4/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:53 PM ET.


Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 18, 2024. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • GE HealthCare Technologies Inc. has recently announced a quarterly dividend of $0.03 per share, providing investors with a steady income stream.
  • BTIG Research upgraded GE HealthCare Technologies from a "neutral" to a "buy" rating with a price target of $100.00, indicating potential for stock price appreciation.
  • GE HealthCare Technologies reported earnings per share of $1.00 for the last quarter, surpassing analyst estimates, showcasing strong financial performance.
  • The company's return on equity stands at 25.26%, indicating efficient utilization of shareholder funds to generate profits.
  • GE HealthCare Technologies Inc. has a consensus rating of "Moderate Buy" with a price target of $93.92, suggesting positive sentiment from analysts and potential growth.

GE HealthCare Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • UBS Group downgraded GE HealthCare Technologies from a "neutral" to a "sell" rating, indicating potential concerns about the company's performance.
  • The stock price of GE HealthCare Technologies Inc. has decreased by 0.5% recently, which may raise doubts about short-term stock performance.
  • GE HealthCare Technologies Inc. has a debt-to-equity ratio of 1.05, suggesting a relatively high level of debt that could impact financial stability.
  • Stifel Nicolaus initiated coverage on GE HealthCare Technologies with a "buy" rating, but the stock has a beta of 1.17, indicating higher volatility compared to the market.
  • One research analyst has rated the stock as a sell, indicating some negative sentiment in the market towards GE HealthCare Technologies Inc.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $94.36, with a high forecast of $110.00 and a low forecast of $74.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There is currently 1 sell rating, 5 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 8.02% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade and 1 downgrade by analysts.

GE HealthCare Technologies has been rated by research analysts at BTIG Research, Evercore ISI, JPMorgan Chase & Co., Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like GE HealthCare Technologies less than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.60 while the average consensus rating score for "medical" companies is 2.79. Learn more on how GEHC compares to other companies.


This page (NASDAQ:GEHC) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners